Variant report

Variant	esv3333436
Chromosome Location	chr19:41446939-41514952
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41506351-41506450	HepG2	liver:	n/a	n/a
2	ARID3A	chr19:41507311-41507499	K562	blood:	n/a	n/a
3	ARID3A	chr19:41486058-41486085	HepG2	liver:	n/a	n/a
4	ATF1	chr19:41468671-41468771	K562	blood:	n/a	n/a
5	ATF3	chr19:41506140-41506734	HCT-116	colon:	n/a	n/a
6	ATF3	chr19:41506267-41506508	K562	blood:	n/a	n/a
7	ATF3	chr19:41468329-41468885	A549	lung:	n/a	n/a
8	ATF3	chr19:41506069-41506786	HCT-116	colon:	n/a	n/a
9	BACH1	chr19:41488176-41489166	H1-hESC	embryonic stem cell:	n/a	n/a
10	BCL3	chr19:41468223-41469050	A549	lung:	n/a	n/a
11	BCL3	chr19:41468291-41469001	A549	lung:	n/a	n/a
12	BHLHE40	chr19:41507420-41507421	K562	blood:	n/a	n/a
13	BRCA1	chr19:41465957-41466156	GM12878	blood:	n/a	n/a
14	CBX3	chr19:41482345-41482685	K562	blood:	n/a	n/a
15	CBX3	chr19:41505993-41506787	HCT-116	colon:	n/a	n/a
16	CBX3	chr19:41460434-41460907	K562	blood:	n/a	n/a
17	CBX3	chr19:41460404-41460899	K562	blood:	n/a	n/a
18	CEBPB	chr19:41505976-41507518	HCT-116	colon:	n/a	chr19:41506435-41506446
19	CEBPB	chr19:41506244-41506603	ECC-1	luminal epithelium:	n/a	chr19:41506435-41506446
20	CEBPB	chr19:41488441-41488804	IMR90	lung:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
21	CEBPB	chr19:41506284-41507442	A549	lung:	n/a	chr19:41506435-41506446
22	CEBPB	chr19:41486382-41486422	K562	blood:	n/a	n/a
23	CEBPB	chr19:41506189-41507135	A549	lung:	n/a	chr19:41506435-41506446
24	CEBPB	chr19:41488308-41488880	A549	lung:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
25	CEBPB	chr19:41506205-41506669	MCF-7	breast:	n/a	chr19:41506435-41506446
26	CEBPB	chr19:41488522-41488635	HepG2	liver:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
27	CEBPB	chr19:41506268-41506934	HepG2	liver:	n/a	chr19:41506435-41506446
28	CEBPB	chr19:41507152-41507489	K562	blood:	n/a	n/a
29	CEBPB	chr19:41488481-41488681	Hela-S3	cervix:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
30	CEBPB	chr19:41488408-41488845	MCF-7	breast:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
31	CEBPB	chr19:41488434-41488797	HepG2	liver:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
32	CEBPB	chr19:41468301-41468559	HepG2	liver:	n/a	n/a
33	CEBPB	chr19:41488422-41488791	A549	lung:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
34	CEBPB	chr19:41468308-41469019	Hela-S3	cervix:	n/a	chr19:41468797-41468810
35	CEBPB	chr19:41488438-41488777	K562	blood:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
36	CEBPB	chr19:41488440-41489019	H1-hESC	embryonic stem cell:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
37	CEBPB	chr19:41486262-41486477	HepG2	liver:	n/a	n/a
38	CEBPB	chr19:41506208-41506618	A549	lung:	n/a	chr19:41506435-41506446
39	CEBPB	chr19:41468165-41469078	A549	lung:	n/a	chr19:41468797-41468810
40	CEBPB	chr19:41507207-41507407	H1-hESC	embryonic stem cell:	n/a	n/a
41	CEBPB	chr19:41468360-41468789	A549	lung:	n/a	n/a
42	CEBPB	chr19:41506068-41507138	HCT-116	colon:	n/a	chr19:41506435-41506446
43	CEBPB	chr19:41506263-41507465	K562	blood:	n/a	chr19:41506435-41506446
44	CEBPB	chr19:41506256-41506628	Hela-S3	cervix:	n/a	chr19:41506435-41506446
45	CEBPB	chr19:41506884-41506987	IMR90	lung:	n/a	n/a
46	CEBPD	chr19:41458422-41458815	K562	blood:	n/a	n/a
47	CHD2	chr19:41465957-41466157	K562	blood:	n/a	n/a
48	CREB1	chr19:41507218-41507529	K562	blood:	n/a	n/a
49	CREB1	chr19:41468563-41468752	A549	lung:	n/a	n/a
50	CREB1	chr19:41486321-41486531	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41510285-41510335	NH-A	brain:	n/a
2	chr19:41510059-41510109	NT2-D1	testis:	n/a
3	chr19:41495942-41495992	HCT-116	colon:	n/a
4	chr19:41496043-41496093	AG09309	skin:	n/a
5	chr19:41510026-41510076	U87	brain:	n/a
6	chr19:41497222-41497272	PANC-1	pancreas:	n/a
7	chr19:41510026-41510076	ProgFib	skin:	n/a
8	chr19:41510037-41510087	AG09309	skin:	n/a
9	chr19:41510243-41510293	GM06990	blood:	n/a
10	chr19:41510098-41510148	AG04449	skin:	fetal
11	chr19:41510285-41510335	SK-N-MC	brain:	n/a
12	chr19:41510098-41510148	Hepatocyte	liver:	n/a
13	chr19:41496749-41496799	BJ	skin:	n/a
14	chr19:41497222-41497272	Hela-S3	cervix:	n/a
15	chr19:41510037-41510087	HUVEC	blood vessel:	n/a
16	chr19:41510037-41510087	HL-60	blood:	n/a
17	chr19:41510026-41510076	SK-N-SH	brain:	n/a
18	chr19:41510059-41510109	AG04449	skin:	fetal
19	chr19:41510243-41510293	SKMC	muscle:	n/a
20	chr19:41496749-41496799	K562	blood:	n/a
21	chr19:41510026-41510076	GM12878	blood:	n/a
22	chr19:41510037-41510087	Caco-2	colon:	n/a
23	chr19:41510272-41510322	PrEC	prostate:	n/a
24	chr19:41510026-41510076	PFSK-1	brain:	n/a
25	chr19:41510098-41510148	HRE	kidney:	n/a
26	chr19:41510037-41510087	HMEC	breast:	n/a
27	chr19:41510059-41510109	GM06990	blood:	n/a
28	chr19:41510285-41510335	CMK	blood:	n/a
29	chr19:41510037-41510087	MCF-7	breast:	n/a
30	chr19:41510037-41510087	NHBE	bronchial:	n/a
31	chr19:41510026-41510076	Jurkat	blood:	n/a
32	chr19:41510098-41510148	NHDF-neo	bronchial:	n/a
33	chr19:41497222-41497272	PrEC	prostate:	n/a
34	chr19:41510098-41510148	HIPEpiC	eye:	n/a
35	chr19:41510243-41510293	HepG2	liver:	n/a
36	chr19:41496749-41496799	HRE	kidney:	n/a
37	chr19:41510272-41510322	Hepatocyte	liver:	n/a
38	chr19:41497222-41497272	HepG2	liver:	n/a
39	chr19:41510026-41510076	HCM	heart:	n/a
40	chr19:41496043-41496093	NHDF-neo	bronchial:	n/a
41	chr19:41495942-41495992	GM12892	blood:	n/a
42	chr19:41497222-41497272	K562	blood:	n/a
43	chr19:41496749-41496799	AoSMC	blood vessel:	n/a
44	chr19:41510243-41510293	IMR90	lung:	fetal
45	chr19:41510285-41510335	HEEpiC	esophagus:	n/a
46	chr19:41510285-41510335	AG09319	gingival:	n/a
47	chr19:41510059-41510109	HepG2	liver:	n/a
48	chr19:41510098-41510148	NT2-D1	testis:	n/a
49	chr19:41510059-41510109	T-47D	breast:	n/a
50	chr19:41510037-41510087	NHDF-neo	bronchial:	n/a

No.	Distal block	Cell Line	Cell type
1	chr19:41480596..41481177-chr19:41649752..41650983,4	K562	blood:
2	chr10:94639799..94640373-chr19:41475219..41475719,2	K562	blood:
3	chr19:41489930..41492049-chr19:41494201..41495851,2	K562	blood:
4	chr19:41458951..41460963-chr19:41463374..41465958,2	K562	blood:
5	chr19:41455358..41456878-chr19:41467418..41469286,2	K562	blood:
6	chr19:41463243..41465087-chr19:41467190..41469905,2	K562	blood:
7	chr19:41463496..41465246-chr19:41466230..41468956,2	K562	blood:
8	chr19:41463243..41465087-chr19:41467190..41469905,2	K562	blood:
9	chr19:41458951..41460963-chr19:41463374..41465958,2	K562	blood:
10	chr19:41436490..41439337-chr19:41447432..41449781,2	MCF-7	breast:
11	chr19:41463496..41465246-chr19:41466230..41468956,2	K562	blood:
12	chr19:41489930..41492049-chr19:41494201..41495851,2	K562	blood:
13	chr19:41455358..41456878-chr19:41467418..41469286,2	K562	blood:
14	chr19:41480412..41481100-chr19:41650028..41650578,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CYP2B6-1	chr19:41492504-41492600	l_1687_chr19:41492503-41503928_testes
2	lnc-CYP2B6-1	chr19:41493177-41493736	l_1687_chr19:41492503-41503928_testes
3	lnc-CYP2B6-1	chr19:41495264-41495408	l_1687_chr19:41492503-41503928_testes
4	lnc-CYP2B6-1	chr19:41493956-41494534	l_1687_chr19:41492503-41503928_testes
5	lnc-CYP2B6-2	chr19:41452252-41452450	ENSG00000269353.1
6	lnc-CYP2B6-2	chr19:41453006-41453355	ENSG00000269353.1
7	lnc-CYP2B6-1	chr19:41503762-41503928	l_1687_chr19:41492503-41503928_testes

Variant related genes	Relation type
CYP2B6	TF binding region
ENSG00000269353	TF binding region
CYP2B7P	TF binding region
CYP2B6	CpG island
ENSG00000269353	CpG island
CYP2B7P	CpG island

Extended variants
information (count: 2808 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:2808 , 50 per page) page: 1 2 3 4 5 6 7 ... 57

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs367668090	chr19:41447000-41447001	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs199903453	chr19:41447020-41447021	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs11882095	chr19:41447021-41447022	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs565428435	chr19:41447033-41447034	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs370764878	chr19:41447042-41447043	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs568155200	chr19:41447051-41447052	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs8192715	chr19:41447095-41447096	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs566097453	chr19:41447134-41447135	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs148719590	chr19:41447136-41447137	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs536680125	chr19:41447137-41447138	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs548679250	chr19:41447155-41447156	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs570180757	chr19:41447166-41447167	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs202078536	chr19:41447185-41447186	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs536846616	chr19:41447205-41447206	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs73557108	chr19:41447231-41447232	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs577016163	chr19:41447233-41447234	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs534625442	chr19:41447237-41447238	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs34331652	chr19:41447269-41447270	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs34110144	chr19:41447273-41447274	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs552517544	chr19:41447324-41447325	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs113444135	chr19:41447332-41447333	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs73931402	chr19:41447334-41447335	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs374430030	chr19:41447340-41447341	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs202166152	chr19:41447365-41447366	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs367658107	chr19:41447410-41447411	Weak transcription Enhancers Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs12986210	chr19:41447427-41447428	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs565498717	chr19:41447464-41447465	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs34151237	chr19:41447479-41447480	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs34013487	chr19:41447486-41447487	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs73038475	chr19:41447492-41447493	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs530114487	chr19:41447496-41447497	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs548644287	chr19:41447497-41447498	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs144841281	chr19:41447510-41447511	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs189816575	chr19:41447515-41447516	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs148283581	chr19:41447517-41447518	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs570640829	chr19:41447522-41447523	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs534541265	chr19:41447528-41447529	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs552824066	chr19:41447556-41447557	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs181595797	chr19:41447560-41447561	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs141247100	chr19:41447565-41447566	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs559785149	chr19:41447570-41447571	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs150780446	chr19:41447587-41447588	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs112958870	chr19:41447592-41447593	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs202105042	chr19:41447601-41447602	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
45	rs80127325	chr19:41447608-41447609	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
46	rs375617137	chr19:41447612-41447613	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
47	rs35182397	chr19:41447613-41447614	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
48	rs397971751	chr19:41447625-41447626	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
49	rs535723007	chr19:41447626-41447627	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
50	rs75141069	chr19:41447628-41447629	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	17431168	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:286 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41432200-41447600	Weak transcription	Liver	Liver
2	chr19:41439200-41447800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
3	chr19:41439200-41448000	Weak transcription	Stomach Mucosa	stomach
4	chr19:41442400-41451400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr19:41442600-41450200	Weak transcription	Lung	lung
6	chr19:41444800-41455800	Weak transcription	Fetal Intestine Large	intestine
7	chr19:41445400-41450200	Weak transcription	Fetal Intestine Small	intestine
8	chr19:41445800-41449200	Enhancers	HUVEC	blood vessel
9	chr19:41446800-41447200	Enhancers	A549	lung
10	chr19:41447200-41447600	Bivalent Enhancer	A549	lung
11	chr19:41447400-41448000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
12	chr19:41447600-41447800	Flanking Bivalent TSS/Enh	A549	lung
13	chr19:41447600-41448200	Strong transcription	Liver	Liver
14	chr19:41447800-41448200	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
15	chr19:41447800-41448200	Bivalent Enhancer	A549	lung
16	chr19:41447800-41448200	Bivalent Enhancer	K562	blood
17	chr19:41448200-41449600	Weak transcription	Liver	Liver
18	chr19:41449600-41451800	Strong transcription	Liver	Liver
19	chr19:41450200-41450400	Bivalent Enhancer	Esophagus	oesophagus
20	chr19:41450200-41450600	ZNF genes & repeats	Lung	lung
21	chr19:41450200-41450800	Strong transcription	Fetal Intestine Small	intestine
22	chr19:41450800-41451800	ZNF genes & repeats	Fetal Intestine Small	intestine
23	chr19:41451400-41451800	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr19:41451400-41452200	Flanking Active TSS	K562	blood
25	chr19:41451800-41452200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr19:41451800-41455200	Weak transcription	Liver	Liver
27	chr19:41451800-41456200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr19:41451800-41456200	Weak transcription	Fetal Intestine Small	intestine
29	chr19:41452200-41452400	Enhancers	K562	blood
30	chr19:41453800-41458200	Weak transcription	Right Atrium	heart
31	chr19:41456200-41456400	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr19:41459600-41460800	ZNF genes & repeats	Duodenum Smooth Muscle	Duodenum
33	chr19:41460000-41460800	ZNF genes & repeats	Brain Hippocampus Middle	brain
34	chr19:41460000-41461600	ZNF genes & repeats	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr19:41460200-41460400	ZNF genes & repeats	A549	lung
36	chr19:41460200-41461400	ZNF genes & repeats	Monocytes-CD14+_RO01746	blood
37	chr19:41464600-41464800	Enhancers	Fetal Intestine Small	intestine
38	chr19:41464800-41466400	Weak transcription	Fetal Intestine Small	intestine
39	chr19:41465200-41466600	Enhancers	Esophagus	oesophagus
40	chr19:41465400-41465800	Bivalent/Poised TSS	ES-UCSF4 Cell Line	embryonic stem cell
41	chr19:41465400-41465800	Active TSS	Breast Myoepithelial Primary Cells	Breast
42	chr19:41465400-41466000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
43	chr19:41465800-41466000	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
44	chr19:41465800-41466000	Flanking Bivalent TSS/Enh	Brain Dorsolateral Prefrontal Cortex	brain
45	chr19:41465800-41466200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
46	chr19:41465800-41466200	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
47	chr19:41465800-41466200	Flanking Bivalent TSS/Enh	Breast Myoepithelial Primary Cells	Breast
48	chr19:41466000-41466200	ZNF genes & repeats	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
49	chr19:41466000-41466200	Bivalent Enhancer	Adipose Nuclei	Adipose
50	chr19:41466000-41466200	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links